1- Associate Professor, Department of Neurology, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. 2- Associate Professor, Department of Social Medicine and Biostatistics, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. , biostat.f@gmail.com 3- GP. Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Abstract: (345 Views)
Background and purpose: Parkinson's disease is the most common movement disorder and the second most common neurodegenerative disease after Alzheimer's. Pain, including headaches, is a common non-motor symptom in Parkinson's disease that worsens over time. With the aging population in Iran, the incidence of Parkinson's disease is expected to rise, necessitating precise planning for healthcare interventions. Headaches are also prevalent non-motor symptoms in these patients, and studying their characteristics can contribute to symptom management and improving quality of life. Materials and methods: In this study, 94 Parkinson's disease patients under neurologist supervision were assessed using questionnaires and medical history evaluations. Demographic characteristics, severity of motor symptoms, and prevalence and characteristics of headaches (frequency and intensity) were evaluated. Results: Among 94 patients, 59 (62/7%) reported headaches. There was no significant association between headache prevalence and gender (P = 0/135). Male Parkinson's patients experienced more moderate to severe headaches compared to females (P = 0/043). There was no significant correlation between headache prevalence and severity of motor symptoms (P = 0/701). The mean headache intensity was 5/6 ± 2/2, indicating moderate intensity, and there was no significant association between headache intensity and motor symptoms (P = 0/127). The frequency of headaches was 6/8 ± 14/1 days in three months, and there was no significant correlation with severity of motor symptoms (P = 0/531). Conclusion: The prevalence of headaches in Parkinson's disease patients is higher compared to the general population, which may be attributed to dysregulation in serotonergic and dopaminergic systems and oxidative stress.
Type of Study: Original |
Subject: General Received: 2024/07/2 | Accepted: 2024/09/18 | Published: 2024/09/18
References
1. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011;26 Suppl 1:S1-58. [DOI:10.1007/s10654-011-9581-6] [PMID]
2. Tysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017 Aug;124(8):901-905. eng. Epub 20170201. [DOI:10.1007/s00702-017-1686-y] [PMID]
3. Hussain G, Rasul A, Anwar H, Sohail MU, Kamran SKS, Baig SM, Shabbir A. Epidemiological data of neurological disorders in Pakistan and neighboring countries: a review. Pakistan Journal of Neurological Sciences (PJNS). 2017;12(4):52-70.
4. Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease. N Engl J Med. 2003 Apr 3;348(14):1356-1364. [DOI:10.1056/NEJM2003ra020003] [PMID]
6. Angelopoulou E, Papadopoulos AN, Spantideas N, Bougea A. Migraine, Tension-Type Headache and Parkinson's Disease: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2022;58(11):1-10. [DOI:10.3390/medicina58111684] [PMID] []
7. Sampaio Rocha-Filho PA, Leite Souza-Lima CF. Parkinson's Disease and Headaches: A Cross-Sectional Study. Headache. 2020;60(5):967-973. [DOI:10.1111/head.13815] [PMID]
8. Fil A, Cano-de-la-Cuerda R, Muñoz-Hellín E, Vela L, Ramiro-González M, Fernández-de-Las-Peñas C. Pain in Parkinson disease: a review of the literature. Parkinsonism Relat Disord. 2013 Mar;19(3):285-294. [DOI:10.1016/j.parkreldis.2012.11.009] [PMID]
9. Lorentz IT. A survey of headache in Parkinson's disease. Cephalalgia. 1989;9(2):83-86.
https://doi.org/10.1046/j.1468-2982.1989.902083.x [DOI:10.1046/j.1468-2982.1989.0902083.x] [PMID]
10. Nunes JC, Costa Bergamaschi EN, Freitas FC, Diaz AP, Queiroz LP, Debona R, et al. Prevalence of headache in patients with Parkinson's disease and its association with the side of motor symptom onset. Neurol Sci. 2014;35(4):595-600. [DOI:10.1007/s10072-013-1571-x] [PMID]
11. Shulman LM, Bhat V. Gender disparities in Parkinson's disease. Expert Rev Neurother. 2006;6(3):407-416. [DOI:10.1586/14737175.6.3.407] [PMID]
12. Peters GL. Migraine overview and summary of current and emerging treatment options. Am J Manag Care. 2019 25(2 Suppl):23-34.
13. Mohammadi P, Khodamorovati M, Vafaee K, Hemmati M, Darvishi N, Ghasemi H. Prevalence of migraine in Iran: a systematic review and meta-analysis. BMC Neurology. 2023 2023;23(1):172-182. [DOI:10.1186/s12883-023-03215-5] [PMID] []
14. Prashanth R, Dutta Roy S. Novel and improved stage estimation in Parkinson's disease using clinical scales and machine learning. Neurocomputing. 2018;305:78-103. [DOI:10.1016/j.neucom.2018.04.049]
15. Rabey J, Korczyn A. The Hoehn and Yahr rating scale for Parkinson's disease. Instrumental methods and scoring in extrapyramidal disorders. Springer; 1995. p. 7-17. [DOI:10.1007/978-3-642-78914-4_2]
16. Roos DS, Klein M, Deeg DJH, Doty RL, Berendse HW. Prevalence of Prodromal Symptoms of Parkinson's Disease in the Late Middle-Aged Population. Journal of Parkinson's Disease. 2022;12:967-974. [DOI:10.3233/JPD-213007] [PMID] []
17. Sampaio Rocha-Filho PA, Leite Souza-Lima CF. Parkinson's Disease and Headaches: A Cross-Sectional Study. Headache: The Journal of Head and Face Pain. 2020;60(5):967-973. [DOI:10.1111/head.13815] [PMID]
18. Angelopoulou E, Papadopoulos AN, Spantideas N, Bougea A. Migraine, Tension-Type Headache and Parkinson's Disease: A Systematic Review and Meta-Analysis. Medicina. 2022;58(11):1684. [DOI:10.3390/medicina58111684] [PMID] []